Bristol-Myers Squibb
BMY
#187
Rank
HK$947.66 B
Marketcap
HK$463.93
Share price
-0.77%
Change (1 day)
33.43%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): HK$35.50

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is HK$35.63. In 2025 the company made an earnings per share (EPS) of HK$27.15 an increase over its 2024 EPS that were of -HK$34.68.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$35.5030.75%
2025HK$27.15-178.28%
2024-HK$34.68-213.92%
2023HK$30.4530.2%
2022HK$23.38-6.04%
2021HK$24.89-179.29%
2020-HK$31.39-281.37%
2019HK$17.31-27.21%
2018HK$23.78
2016HK$20.95175.26%
2015HK$7.61-19.83%
2014HK$9.50-22.44%
2013HK$12.2434.48%
2012HK$9.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.54 92.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$52.26 46.70%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.96-83.26%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$28.02-21.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$234.50 558.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$127.28 257.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$14.93-58.09%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
HK$44.57 25.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$9.93-72.12%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$52.42 47.14%๐Ÿ‡ฌ๐Ÿ‡ง UK